Tuesday, October 19, 2010

Global market for CNS therapeutic drug market to reach $81.8 billion by 2015

The overall central nervous system therapeutic drug market is valued at an estimated $78 billion in 2010. This market will experience a nominal reduction in the early portion of the forecast period, and then slowly rise at a compound annual growth rate (CAGR) of 0.7% to reach nearly $81.8 billion by 2015.

Learn about the central nervous system therapies on a global basis and get detailed product analyses within disease sub–segments to overall industry trends. Also included in this report is information on markets by geography, pipeline analysis and company profiles...

Use this report to:
  • Understand each core segment within the overall CNS therapeutic drug market, and how the leading products within each segment are differentiated
  • Develop strategies for accessing emerging markets and specific disease segments in order to allocate resources and make effective decisions
  • Learn from the strategies of leading manufacturers as well as biotechnology companies with novel products in development
  • Prepare for the introduction of new products during the forecast period in terms of how these introductions will change the face of the competitive environment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

No comments:

Post a Comment

Bookmark and Share